AEON
AEON
AMEX · N/A

Aeon Biopharma Inc

$1.10
+0.03 (+2.80%)
As of Feb 8, 2:23 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 19.22M 20.30M 17.77M
Net Income 1.18M 1.16M 1.21M
EPS
Profit Margin 6.1% 5.7% 6.8%
Rev Growth +20.2% +6.7% +16.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 7.62M 6.60M 7.98M
Total Equity 11.32M 11.40M 10.22M
D/E Ratio 0.67 0.58 0.78
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 2.01M 2.27M 2.16M
Free Cash Flow 1.07M 1.22M 952.2K